Indication
Acute Hepatic Porphyria
2 clinical trials
2 products
Clinical trial
ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study With an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients With Acute Hepatic PorphyriasStatus: Completed, Estimated PCD: 2019-01-31
Product
PlaceboProduct
Givosiran